Journal: Cellular and Molecular Immunology
Article Title: Oncolytic virus M1 reinvigorates CD8 + T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen
doi: 10.1038/s41423-026-01396-w
Figure Lengend Snippet: OVM exhibits antiglioma activity. A Glioma cell lines GL261, CT2A, U-87 MG, and U-118 MG were infected with OVM at MOIs of 0.001, 0.01, 0.1, 1, and 10, respectively. Cell viability was assessed via the MTT assay at 24, 48, 72, and 96 h postinfection. B Glioma apoptosis was evaluated by Annexin V/PI staining following infection with OVM at an MOI of 1 for 48 h. C Quantification of early apoptotic cells (Annexin V + PI − ) and late apoptotic cells (Annexin V + PI + ). D Schematic of the in vivo treatment schedule. Glioma cells (GL261, CT2A, or GL261-Luc) were intracranially implanted on Day 0, followed by daily tail vein injections of vehicle or OVM from Day 5 to Day 9. E Bioluminescence imaging of GL261-Luc tumors was performed via the IVIS Spectrum system on days 13, 17, and 20. F Tumor burden was quantified by total flux (photons/second). OS of GL261 ( G ) and CT2A ( H ) orthotopic tumor-bearing mice treated with OVM was assessed and represented by Kaplan‒Meier survival curves. I Kaplan‒Meier survival curves of GBM patients from the CGGA database stratified by MXRA8 expression. J Analysis of MXRA8 expression across classical, mesenchymal and proneural GBM subtypes in the CGGA database. K Human glioma tissue fragments (~1 mm³) were treated with OVM (150 µL, 1.16 × 10 8 CCID 50 /mL), vehicle, or TMZ (50 mg/mL) for 72 h. Viral replication was quantified via qPCR, and replication coefficients were calculated as the ratio of viral copies in standard culture to those in parallel inactivated controls; a coefficient >2 indicated productive viral replication. Tissue viability was assessed by MTT staining
Article Snippet: The cells were washed once with precooled PBS, recentrifuged, and resuspended in 100 μL of 1× Annexin V Binding Buffer (from the Annexin V-APC/PI Apoptosis Kit, Elabscience, E-CK-A217) to a concentration of 1 × 10 6 cells/mL.
Techniques: Activity Assay, Infection, MTT Assay, Staining, In Vivo, Imaging, Expressing